A detailed history of Colonial Trust CO / Sc transactions in Exact Sciences Corp stock. As of the latest transaction made, Colonial Trust CO / Sc holds 300 shares of EXAS stock, worth $20,940. This represents 0.0% of its overall portfolio holdings.

Number of Shares
300
Previous 322 6.83%
Holding current value
$20,940
Previous $22,000 45.45%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$41.33 - $74.26 $909 - $1,633
-22 Reduced 6.83%
300 $12,000
Q1 2024

May 13, 2024

BUY
$56.27 - $73.77 $112 - $147
2 Added 0.63%
322 $22,000
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $1,181 - $1,514
20 Added 6.67%
320 $23,000
Q4 2022

Feb 14, 2023

BUY
$30.35 - $53.15 $9,105 - $15,945
300 New
300 $14,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12.4B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Colonial Trust CO / Sc Portfolio

Follow Colonial Trust CO / Sc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colonial Trust CO / Sc, based on Form 13F filings with the SEC.

News

Stay updated on Colonial Trust CO / Sc with notifications on news.